After informed consent was obtained, the patient was brought into the cardiac catheterization laboratory and prepped and draped in the usual sterile fashion.Coronary angiography was initially performed.Findings include a type iii lad.There is what appears to be a 60-70% lesion in the lad with dpr showing that this was significant.The team decided to proceed with intervention of the mid lad.When it was time for the synergy xd to be used, device was removed from the packaging and it was found to be defective with the end of shaft broken.The device was never inside the patient.This was replaced by another similar device and the procedure was completed without any further incident.No patient harm.Manufacturer response for coronary drug-eluting stent, synergy¿ xd (per site reporter.) device given to field representative.
|